Business Overview
This is a rare opportunity to acquire a complete, high-capacity industrial facility specialized in the extraction of Crude Heparin from porcine intestinal mucosa. The plant represents a turnkey investment in the high-margin pharmaceutical ingredients sector.
The facility is being offered as a total business asset, featuring a fully integrated technological line designed for large-scale operations. It is an ideal acquisition for pharmaceutical companies, biotech firms, or large-scale meat processors looking to vertically integrate and monetize biological by-products.
Facility & Asset Infrastructure
The sale includes the entire production plant and all auxiliary systems required for a closed-loop manufacturing process:
Massive Reactor Farm: A high-performance reactor line with a total processing volume of 240 m³. Each reactor is engineered from heavy-duty, acid-resistant stainless steel and features:
Fully insulated heating jackets for precise enzymatic hydrolysis control.
Reinforced mechanical agitators designed for high-density organic loads.
The Complete Production Chain: Unlike an equipment auction, this is a functional plant including:
Separation Suite: Industrial centrifuges and filter presses for phase separation.
Adsorption Department: Advanced ion-exchange columns for selective heparin capture.
Fluid Logistics: A comprehensive network of acid-resistant piping, automated pumping stations, and industrial process valves.
Advanced Automation & Hygiene: Centralized PLC control systems (monitoring pH, temperature, and reaction cycles) and integrated Clean-in-Place (CIP) systems to meet pharmaceutical standards.
Key Investment Highlights
Turnkey Ready: The facility is a complete operational unit. An investor can bypass the 18–24 month lead time required for greenfield design, permitting, and construction.
Industrial Scale: Designed to handle raw material volumes from the largest slaughterhouses in Europe.
Strategic Location: Located in Poland (Central Europe), offering a highly competitive operational cost base and excellent logistics to global markets.
High Versatility: While optimized for Heparin, the infrastructure is perfectly suited for producing peptones, protein hydrolysates, or premium organic fertilizers.
